Hypereosinophilic syndrome and hemimelia in a patient with chromosome 6p22.3 deletion

Pediatric Allergy and Immunology

Volumn 25, Issue 5, 2014, Pages 500-503

  Ladinsky, Hava T ^a   Elizalde, Araceli ^a   Schickler, Robyn ^b   Dees, Paola B ^c   Crenshaw, Melissa L ^c   Sleasman, John W ^d  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA; PREDNISONE;

BONE MARROW EXAMINATION; CHROMOSOME 6P; CHROMOSOME DELETION; COMPUTER ASSISTED TOMOGRAPHY; FLUORESCENCE IN SITU HYBRIDIZATION; HEMIMELIA; HUMAN; HYPEREOSINOPHILIC SYNDROME; LETTER; PRIORITY JOURNAL; ULTRASOUND; CASE REPORT; CHROMOSOME 6; GENETICS; INFANT; MALE; MULTIPLE MALFORMATION SYNDROME; NEWBORN; PHOCOMELIA;

ABNORMALITIES, MULTIPLE; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 6; ECTROMELIA; HUMANS; HYPEREOSINOPHILIC SYNDROME; INFANT; INFANT, NEWBORN; MALE;

EID: 84907597962     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/pai.12213     Document Type: Letter

References (10)

1. Mirza G, Williams RR, Mohammed S, et al. Refined genotype-phenotype correlations in cases of chromosomal 6p deletion syndromes. Eur J Hum Genet 2004: 12: 718-28.
2. Klion AD, Bochner BS, Gleich GJ, et al. Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol 2006: 117: 1292-302.
3. Strouse J, Lanzkron S, Beach M, et al. Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children. Pediatrics 2008: 122: 1332-42.
4. Simon HU, Rothenberg ME, Bochner BS, et al. Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol 2010: 126: 45-9.
5. Zittoun J, Farcet JP, Marquet J, Sultan C, Zittoun R. Cobalamin (vitamin B12) and B12 binding proteins in hypereosinophilic syndromes and secondary eosinophilia. Blood 1984: 63: 779-83.
6. Ogbogu PU, Bochner BS, Butterfield JH, et al. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol 2009: 124: 1319-25.e3.
7. Kou ZC, Puhr JS, Wu SS, et al. Combination antiretroviral therapy results in a rapid increase in T cell receptor variable region beta repertoire diversity within CD45RA CD8 T cells in human immunodeficiency virus-infected children. J Infect Dis 2003: 187: 385-97.
8. Ravoet M, Sibille C, Gu C, et al. Molecular profiling of CD3(-)CD4(+) T-cells from patients with the lymphocytic variant of hypereosinophillic syndrome reveals targeting of growth control pathways. Blood 2009: 114: 2969-83.
9. de Lavareille A, Roufosse F, Schmid-Grendelmeier P, et al. High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophillic syndrome. J Allergy Clin Immunol 2002: 110: 476-9.
10. Fujisawa T, Nagao M, Hiraguchi Y, et al. Measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis. Pediatr Allergy Immunol 2009: 20: 633-41.